Robert G. Maki
Memorial Sloan Kettering Cancer Center(US)Cornell University(US)Kettering University(US)Eastern Health(AU)Hiroshima City Asa Citizens Hospital(JP)University of Pennsylvania(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment, Vascular Tumors and Angiosarcomas, Cardiac tumors and thrombi, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer(2010)4,491 cited
- → A framework for advancing our understanding of cancer-associated fibroblasts(2020)3,626 cited
- → A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains(2000)2,099 cited
- → Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial(2012)1,392 cited
- → Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial(2017)1,375 cited
- → Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial